3min chapter

Bloomberg Intelligence cover image

Eli Lilly to Purchase Morphic, Green Hydrogen

Bloomberg Intelligence

CHAPTER

Discussion on Eli Lilly's Acquisition of Morphic and Drug Pricing in the Pharmaceutical Industry

This chapter delves into Eli Lilly's $3.2 billion acquisition of Morphic, M&A trends in healthcare, discussions on drug pricing, middlemen in the pharmaceutical industry, and the importance of competition to reduce prices. The chapter also introduces Sam Fazelli, a healthcare pharma analyst, and mentions Think or Swim trading platform and CrowdStrike cybersecurity platform.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode